Is Novo Nordisk Stock a Buy?
29/11 11:35
Few companies garner as much reliable attention as Novo Nordisk (NYSE: NVO) does these days. With a bull market coinciding with a historic run of growth for the Danish pharmaceutical giant related to its GLP-1 drugs, it's no surprise that its share prices have nearly doubled over...